Error: Could not add to watchlist. X
+ Watchlist

Amicus Therapeutics Inc

FOLD:US
NASDAQ GM
7.17
USD
0.10
1.41%
As of 10:02 AM EDT 3/23/2017
Open
7.05
Day Range
6.97 - 7.18
Volume
161,763
Previous Close
7.07
52Wk Range
4.41 - 9.83
1 Yr Return
-6.27%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
7.05
Day Range
6.97 - 7.18
Volume
161,763
Previous Close
7.07
52Wk Range
4.41 - 9.83
1 Yr Return
-6.27%
YTD Return
44.27%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.35
Market Cap (b USD)
1.009
Shares Outstanding (m)
142.741
Price/Sales (TTM)
205.05
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.12%
% Price Change
-0.15%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
Profile
Amicus Therapeutics, Inc. is a biopharmaceutical company that develops orally-administered, small molecule drugs to treat human genetic diseases. The drugs, called pharmacological chaperones, are being developed to treat Fabray, Gaucher, and Pompe disease.
Address
1 Cedar Brook Drive
Cranbury, NJ 08512
United States
Phone
1-609-662-2000
Show More